We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CLIS:TASEClal Insurance Enterprises Holdings Limited Analysis

Data as of 2026-06-12 - not real-time

ILA 25,790.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Clal Insurance trades at roughly 7.6% of its discounted cash‑flow estimate, with a market price of 25,790 versus a DCF fair value of 338,603, suggesting a deep discount. The stock’s PE ratio of 9.3 is well below the industry average of 16.6, while the price‑to‑book of 1.9 and dividend yield of 1.95% indicate attractive value and sustainable income given a modest payout ratio of 9%. Fundamentals remain solid: revenue grew 6.6% YoY, operating margin sits near 27%, and free cash flow of over 16.4 billion underscores strong liquidity.
Technical signals are mixed: the price sits below the 20‑day (26,925) and 50‑day (26,197) SMAs, the RSI at 44 signals neutral momentum, and a bearish MACD histogram (-285) points to short‑term downside pressure, though the broader trend is still classified as bullish. Volume is increasing, supporting the potential for a bounce toward the identified resistance around 29,440.
Risk considerations include a relatively low beta of 0.25 and a 30‑day volatility of nearly 39%, indicating price swings but limited market‑wide correlation. The company’s strong cash position, low debt‑to‑equity concerns (despite a high absolute debt figure), and limited regulatory and currency exposure make the downside risk manageable, aligning with a medium‑term upside thesis.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram indicating short‑term downside
  • Price below 20‑day and 50‑day SMAs
  • RSI near neutral territory

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap between market price and DCF fair value
  • Strong free cash flow and low payout ratio supporting dividend sustainability
  • Increasing volume suggesting accumulation

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Robust ROE (~23%) and stable operating margins
  • Low beta and defensive insurance sector profile
  • Attractive yield and ample liquidity for future growth

Key Metrics & Analysis

Financial Health

Revenue Growth6.60%
Profit Margin13.30%
P/E Ratio9.3
ROE22.88%
ROA2.19%
Debt/Equity166.43
P/B Ratio1.9
Op. Cash FlowILA1.1B
Free Cash FlowILA16.5B
Industry P/E16.6

Technical Analysis

TrendBullish
RSI44.0
SupportILA 24,450.00
ResistanceILA 29,440.00
MA 20ILA 26,925.00
MA 50ILA 26,197.20
MA 200ILA 21,767.35
MACDBearish
VolumeIncreasing
Fear & Greed Index87.79

Valuation

Fair ValueILA 338,603.45
Target PriceILA 29,000.00
Upside/Downside12.45%
GradeUndervalued
TypeBlend
Dividend Yield1.95%

Risk Assessment

Beta0.25
Volatility38.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.